BIOLOGÍA MOLECULAR Y CELULAR EN HEMOPATÍAS

Foto de BIOLOGÍA MOLECULAR Y CELULAR EN HEMOPATÍAS

Foto de Fondazione IRCCS Istituto Nazionale dei Tumori

Fondazione IRCCS Istituto Nazionale dei Tumori

Milán, Italia

Publications in collaboration with researchers from Fondazione IRCCS Istituto Nazionale dei Tumori (6)

2024

Decoding the historical tale: COVID-19 impact on haematological malignancy patients—EPICOVIDEHA insights from 2020 to 2022
eClinicalMedicine, Vol. 71
Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey
Infection

2023

Impact of SARS-CoV-2 vaccination and monoclonal antibodies on outcome post–CD19-directed CAR T-cell therapy: an EPICOVIDEHA survey
Blood Advances, Vol. 7, Núm. 11, pp. 2645-2655

2022

Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey
Blood, Vol. 140, Núm. 26, pp. 2773-2787
Outcome of infection with omicron SARS-CoV-2 variant in patients with hematological malignancies: An EPICOVIDEHA survey report
American Journal of Hematology

2021

COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA)
Journal of Hematology and Oncology, Vol. 14, Núm. 1